Novartis to acquire breast cancer drug developer for up to $3 billion
Go back to Novartis to acquire breast cancer drug developer for up to $3 billion| NOVARTIS AG (NYSE: NVS) | Delayed: 151.58 +2.65 (1.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $148.93 | 52 Week High | $89.15 | |||
| Open | $151.94 | 52 Week Low | $69.84 | |||
| Day High | $152.53 | P/E | N/A | |||
| Day Low | $151.58 | EPS | $0.00 | |||
| Volume | 351,716 | |||||
